Researchers at cancer centers in Canada, the United Kingdom and the U.S., including the Miller School of Medicine’s Sylvester Comprehensive Cancer Center, have developed a breakthrough diagnostic test to identify which men are most likely to have a recurrence of prostate cancer after localized treatment with surgery or radiotherapy.
The Life Raft Group has named Stephen Nimer, M.D., Director of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, its Humanitarian of the Year. Dr. Nimer was presented the award at the 7th anniversary of the biennial Life Fest convention, a unique event where hundreds of Gastrointestinal Stromal Tumor (GIST) patients and caregivers gather for a weekend of camaraderie.
Researchers at the Sylvester Comprehensive Cancer Center, in collaboration with Johns Hopkins University, have found that Tadalafil, commonly known as Cialis, can be therapeutic for certain types of cancer. When used before surgery, Tadalafil can reduce certain cells that are detrimental to head and neck squamous cell carcinoma patients’ prognoses.
Erin Kobetz, Ph.D., M.P.H., Associate Director for Disparities and Community Outreach for the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has been awarded a grant from the GE Foundation to help improve the prevention of cervical cancer in women living in medically underserved areas.
More than 400 guests who attended Sylvester Comprehensive Cancer Center’s WellBeingWell conference were asked to imagine a day when cancer is no longer the scourge of our time, but a chronic condition that can be treated. That message of hope was delivered at the conference held Thursday at the JW Marriott Marquis Miami Hotel.
A team of scientists led by Ramin Shiekhattar, Ph.D., professor of biochemistry and molecular biology and human genetics, has identified an important mechanism that could be deregulated in cancer.
The Division of Continuing Medical Education will host Synergy 2014 November 14-16 at the Eden Roc Miami Beach, 4525 Collins Avenue. The annual symposium provides a review of a variety of oncological diseases, combined with the latest developments in medical, interventional and surgical therapeutic options across multiple disciplines.
The St. Baldrick’s Foundation, a volunteer-driven and donor-centered charity dedicated to raising money for childhood cancer research, has awarded a one-year infrastructure grant of $50,000 to John Goldberg, M.D., Director of the Pediatric Oncology Early Phase Clinical Trials Program at Sylvester Comprehensive Cancer Center and Assistant Professor of Pediatrics at the Miller School of Medicine.